Commercially available antibodies against human and murine histamine H 4-receptor lack specificity

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 385, Issue 2, 2012, Pages 125-135

  Beermann, Silke ^a   Seifert, Roland ^a   Neumann, Detlef ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Antibody specificity; Flow cytometry; Histamine receptor; Western blotting

Indexed keywords

CD20 ANTIBODY; HISTAMINE H4 RECEPTOR; HISTAMINE H4 RECEPTOR ANTIBODY; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN SPECIFICITY; ARTICLE; BLOOD; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SPLEEN CELL; WESTERN BLOTTING; WILD TYPE;

ANIMALS; ANTIBODIES; ANTIBODY SPECIFICITY; BACULOVIRIDAE; CELL LINE; HEK293 CELLS; HUMANS; LEUKOCYTES, MONONUCLEAR; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, HISTAMINE; SPODOPTERA; TRANSFECTION;

EID: 84857032099     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/s00210-011-0700-4     Document Type: Article

References (40)

1. W Bäumer S Wendorff R Gutzmer T Werfel D Dijkstra P Chazot H Stark M Kietzmann 2008 Histamine H4 receptors modulate dendritic cell migration through skin-immunomodulatory role of histamine Allergy 63 1387 1394 18782117 10.1111/j.1398-9995.2008.01720.x
2. S Bodei N Arrighi P Spano S Sigala 2009 Should we be cautious on the use of commercially available antibodies to dopamine receptors? Naunyn Schmiedebergs Arch Pharmacol 379 413 415 19096766 10.1007/s00210-008-0384-6 1:CAS:528:DC%2BD1MXitFKisbw%3D
3. DB Bylund ML Toews 2011 Radioligand binding methods for membrane preparations and intact cells Methods Mol Biol 746 135 164 21607856 10.1007/978-1-61779-126-0-8
4. 4-receptor gene Biochem Biophys Res Commun 284 301 309 11394877 10.1006/bbrc.2001.4976 (Pubitemid 32917975)
5. 4 receptor as a new therapeutic target for inflammation Trends Pharmacol Sci 26 462 469 16054239 (Pubitemid 41207878)
6. AR de Sousa LO Penalva EM Marcotte C Vogel 2009 Global signatures of protein and mRNA expression levels Mol Biosyst 5 1512 1526
7. 4 receptor J Invest Dermatol 128 1696 1703 18239617 10.1038/sj.jid.5701250 1:CAS:528:DC%2BD1cXntVertrc%3D (Pubitemid 351847377)
8. 4 receptor: modulation of cell migration and function Allergy 65 840 849 19958313 10.1111/j.1398-9995.2009.02279.x 1:CAS:528:DC%2BC3cXptFOgsLo%3D
9. SJ Hill CR Ganellin H Timmerman JC Schwartz NP Shankley JM Young W Schunack R Levi HL Haas 1997 International Union of Pharmacology. XIII. Classification of histamine receptors Pharmacol Rev 49 253 278 9311023 1:CAS:528:DyaK2sXmtl2hsbo%3D (Pubitemid 27414915)
10. 4 receptor mediates chemotaxis and calcium mobilization of mast cells J Pharmacol Exp Ther 305 1212 1221 12626656 10.1124/jpet.102.046581 1:CAS:528:DC%2BD3sXkt1Snt7c%3D (Pubitemid 36618001)
11. S Holmseth KP Lehre NC Danbolt 2006 Specificity controls for immunocytochemistry Anat Embryol (Berl) 211 257 266 10.1007/s00429-005-0077-6 1:CAS:528:DC%2BD28XnslSjt7g%3D (Pubitemid 44421066)
12. LB Hough 2001 Genomics meets histamine receptors: new subtypes, new receptors Mol Pharmacol 59 415 419 11179433 1:CAS:528:DC%2BD3MXhs1Ojsr4%3D (Pubitemid 32179917)
13. BC Jensen PM Swigart PC Simpson 2009 Ten commercial antibodies for alpha-1-adrenergic receptor subtypes are nonspecific Naunyn Schmiedebergs Arch Pharmacol 379 409 412 18989658 10.1007/s00210-008-0368-6 1:CAS:528: DC%2BD1MXitFKisbY%3D
14. M Jongsma UM Florczyk MC Hendriks-Balk MC Michel SL Peters AE Alewijnse 2007 Validation of a rapid, non-radioactive method to quantify internalisation of G-protein coupled receptors Naunyn Schmiedebergs Arch Pharmacol 375 329 336 17497135 10.1007/s00210-007-0164-8 1:CAS:528:DC%2BD2sXmsFKitrs%3D (Pubitemid 46945334)
15. M Keller D Erdmann N Pop N Pluym S Teng G Bernhardt A Buschauer 2011 Red-fluorescent argininamide-type NPY Y1 receptor antagonists as pharmacological tools Bioorg Med Chem 19 2859 2878 21493077 10.1016/j.bmc.2011.03.045 1:CAS:528:DC%2BC3MXltFOrsL0%3D
16. U Klein MT Ramirez BK Kobilka M von Zastrow 1997 A novel interaction between adrenergic receptors and the alpha-subunit of eukaryotic initiation factor 2B J Biol Chem 272 19099 19102 9235896 10.1074/jbc.272.31.19099 1:CAS:528:DyaK2sXltFSntbw%3D (Pubitemid 27337693)
17. 4R antibody Inflamm Res 59 Suppl 2 S197 S198 20020316 10.1007/s00011-009-0127-2 1:CAS:528:DC%2BC3cXjtVGjsbg%3D
18. 4 receptor Br J Pharmacol 157 14 23 19413568 10.1111/j.1476-5381.2009.00250.x 1:CAS:528:DC%2BD1MXlsVWlsrc%3D
19. R Leurs HF Vischer M Wijtmans IJ de Esch 2011 En route to new blockbuster anti-histamines: surveying the offspring of the expanding histamine receptor family Trends Pharmacol Sci 32 250 257 21414671 10.1016/j.tips.2011.02.004 1:CAS:528:DC%2BC3MXksFGru7w%3D
20. P Lieberman 2011 The basics of histamine biology Ann Allergy Asthma Immunol 106 S2 S5 21277530 10.1016/j.anai.2010.08.005
21. 4) expressed in bone marrow Mol Pharmacol 59 420 426 11179434 1:CAS:528:DC%2BD3MXhs1Ojsr8%3D (Pubitemid 32179918)
22. 4 receptors reveals substantial pharmacological species variation J Pharmacol Exp Ther 299 121 130 11561071 1:CAS:528:DC%2BD3MXntFWlt70%3D (Pubitemid 32905126)
23. MC Michel T Wieland G Tsujimoto 2009 How reliable are G-protein-coupled receptor antibodies? Naunyn Schmiedebergs Arch Pharmacol 379 385 388 19172248 10.1007/s00210-009-0395-y 1:CAS:528:DC%2BD1MXitFKitr8%3D
24. S Miyauchi A Hirasawa T Iga N Liu C Itsubo K Sadakane T Hara G Tsujimoto 2009 Distribution and regulation of protein expression of the free fatty acid receptor GPR120 Naunyn Schmiedebergs Arch Pharmacol 379 427 434 19145429 10.1007/s00210-008-0390-8 1:CAS:528:DC%2BD1MXitFKisLs%3D
25. KL Morse J Behan TM Laz RE West SA Greenfeder JC Anthes S Umland Y Wan RW Hipkin W Gonsiorek N Shin EL Gustafson X Qiao S Wang JA Hedrick J Greene M Bayne FJ Monsma 2001 Cloning and characterization of a novel human histamine receptor J Pharmacol Exp Ther 296 1058 1066 11181941 1:CAS:528: DC%2BD3MXhtlOksLY%3D (Pubitemid 32187382)
26. J Myslivecek M Klein M Novakova J Ricny 2008 The detection of the non-M2 muscarinic receptor subtype in the rat heart atria and ventricles Naunyn Schmiedebergs Arch Pharmacol 378 103 116 18443764 10.1007/s00210-008-0285-8 1:CAS:528:DC%2BD1cXnsVSmu7c%3D
27. 4R Biochem Biophys Res Commun 279 615 620 11118334 10.1006/bbrc.2000.4008 1:CAS:528:DC%2BD3cXovVCmsr0%3D (Pubitemid 32016763)
28. T Oda N Morikawa Y Saito Y Masuho S Matsumoto 2000 Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes J Biol Chem 275 36781 36786 10973974 10.1074/jbc.M006480200 1:CAS:528:DC%2BD3cXoslWlsrs%3D (Pubitemid 32002087)
29. W Pradidarcheep WT Labruyère NF Dabhoiwala WH Lamers 2008 Lack of specificity of commercially available antisera: better specifications needed J Histochem Cytochem 56 1099 1111 18796405 10.1369/jhc.2008.952101 1:CAS:528:DC%2BD1cXhsVaitbzE
30. W Pradidarcheep J Stallen WT Labruyère NF Dabhoiwala MC Michel WH Lamers 2009 Lack of specificity of commercially available antisera against muscarinergic and adrenergic receptors Naunyn Schmiedebergs Arch Pharmacol 379 397 402 19198807 10.1007/s00210-009-0393-0 1:CAS:528:DC%2BD1MXitFKisLk%3D
31. EH Schneider R Seifert 2010 Coexpression systems as models for the analysis of constitutive GPCR activity Methods Enzymol 485 527 557 21050935 10.1016/B978-0-12-381296-4.00028-2 1:CAS:528:DC%2BC3cXhs1Smt7%2FJ
32. EH Schneider R Seifert 2010 Fusion proteins as model systems for the analysis of constitutive GPCR activity Methods Enzymol 485 459 480 21050932 10.1016/B978-0-12-381296-4.00025-7 1:CAS:528:DC%2BC3cXhs1Smt7%2FO
33. EH Schneider R Seifert 2010 Sf9 cells: a versatile model system to investigate the pharmacological properties of G protein-coupled receptors Pharmacol Ther 128 387 418 20705094 10.1016/j.pharmthera.2010.07.005 1:CAS:528:DC%2BC3cXhtlKhs7%2FJ
34. 4-receptor Biochemistry 48 1424 1438 19166345 10.1021/bi802050d 1:CAS:528:DC%2BD1MXpslyqsQ%3D%3D
35. 3-receptors Biochem Pharmacol 80 1437 1449 20688049 10.1016/j.bcp.2010.07.027 1:CAS:528:DC%2BC3cXhtFyitbnP
36. 4 receptors in Sf9 insect cells Naunyn Schmiedebergs Arch Pharmacol 383 457 470 21359967 10.1007/s00210-011-0612-3 1:CAS:528: DC%2BC3MXlt1Gmtbg%3D
37. 4 receptors in allergic inflammation: the search for new antihistamines Nat Rev Drug Discov 7 41 53 18172439 10.1038/nrd2465 1:CAS:528:DC%2BD1cXht1ygsQ%3D%3D
38. 4 receptors Mol Pharmacol 70 604 615 16645125 10.1124/mol.105.020818 (Pubitemid 44092321)
39. W Vrydag MC Michel 2007 Tools to study beta3-adrenoceptors Naunyn Schmiedebergs Arch Pharmacol 374 385 398 17211601 10.1007/s00210-006-0127-5 1:CAS:528:DC%2BD2sXhsVersrs%3D (Pubitemid 46215287)
40. Y Zhu D Michalovich H Wu KB Tan GM Dytko IJ Mannan R Boyce J Alston LA Tierney X Li NC Herrity L Vawter HM Sarau RS Ames CM Davenport JP Hieble S Wilson DJ Bergsma LR Fitzgerald 2001 Cloning, expression, and pharmacological characterization of a novel human histamine receptor Mol Pharmacol 59 434 441 11179436 1:CAS:528:DC%2BD3MXhs1Ojsr0%3D (Pubitemid 32179920)